SEC Form 4 · accession 0000899243-16-034974
NovoCure Ltd · NVCR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Eilon D. Kirson
Officer — Chief Scientific Officer
Period of report
Dec 5, 2016
Accepted (ET)
Dec 6, 2016 · 4:05 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001645113
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Dec 5, 2016 | M | 156,073 | $0.17 | A | 334,083 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Options to buy Ordinary SharesF1 | $0.17 | Dec 5, 2016 | M | 156,073 | D | — | Dec 12, 2016 | Ordinary Shares | 156,073 | 0 | D |
Explanation of responses
- F1Fully vested and currently exercisable as of the date hereof.